Published in Endocrinology on March 30, 2006
Inhibition of brain proinflammatory cytokine synthesis reduces hypothalamic excitation in rats with ischemia-induced heart failure. Am J Physiol Heart Circ Physiol (2008) 1.36
Angiotensin II AT1 receptor blockade prevents the hypothalamic corticotropin-releasing factor response to isolation stress. Brain Res (2007) 1.01
Gene expression profiling following maternal deprivation: involvement of the brain Renin-Angiotensin system. Front Mol Neurosci (2009) 0.87
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats. Br J Pharmacol (2014) 0.87
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. Br J Pharmacol (2012) 0.85
Inhibition of cyclooxygenase-2 reduces hypothalamic excitation in rats with adriamycin-induced heart failure. PLoS One (2012) 0.83
Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism. Br J Pharmacol (2012) 0.82
Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.80
Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress. Behav Brain Res (2012) 0.80
Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats. Br J Pharmacol (2014) 0.79
Stress-dependent hypertension and the role of T lymphocytes. Exp Physiol (2012) 0.79
Hypertension, RAS, and gender: what is the role of aminopeptidases? Heart Fail Rev (2008) 0.78
Fear-potentiated behaviour is modulated by central amygdala angiotensin II AT1 receptors stimulation. Biomed Res Int (2014) 0.76
Impaired adrenergic- and corticotropic-axis outflow during exercise in chronic obstructive pulmonary disease. Metabolism (2011) 0.76
The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats. Br J Pharmacol (2016) 0.76
Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice. Physiol Genomics (2016) 0.75
Glucagon increase after chronic AT1 blockade is more likely related to an indirect leptin-dependent than to a pancreatic α-cell-dependent mechanism. Naunyn Schmiedebergs Arch Pharmacol (2017) 0.75
Genomewide association analysis of coronary artery disease. N Engl J Med (2007) 24.38
The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke (2003) 4.63
Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol (2004) 3.18
Organotypic slice culture from human adult ventricular myocardium. Cardiovasc Res (2011) 1.78
Microalbuminuria and tubular proteinuria as risk predictors of cardiovascular morbidity and mortality in essential hypertension: final results of a prospective long-term study (MARPLE Study)*. J Hypertens (2006) 1.74
To dip or not to dip: on the physiology of blood pressure decrease during nocturnal sleep in healthy humans. Hypertension (2007) 1.61
Differential expression of AT1 receptors in the pituitary and adrenal gland of SHR and WKY. Hypertension (2003) 1.61
Evidence for lower sympathetic nerve activity in young adults with low birth weight. J Hypertens (2003) 1.61
High-fat diet-induced hyperinsulinemia and tissue-specific insulin resistance in Cry-deficient mice. Am J Physiol Endocrinol Metab (2013) 1.57
Use of surveillance criteria reduces interstage mortality after the Norwood operation for hypoplastic left heart syndrome. Eur J Cardiothorac Surg (2011) 1.55
Effects of selective angiotensin II receptor blockade on sympathetic nerve activity in primary hypertensive subjects. J Hypertens (2002) 1.54
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension. J Hypertens (2003) 1.53
Comparison of the vascular and antiadrenergic activities of four angiotensin II type 1 antagonists in the pithed rat. J Hypertens (2002) 1.40
Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovasc Res (2002) 1.31
Acute reduction of myocardial infarct size by a hydroxymethyl glutaryl coenzyme A reductase inhibitor is mediated by endothelial nitric oxide synthase. J Cardiovasc Pharmacol (2003) 1.19
Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase/Akt pathway. J Cardiovasc Pharmacol (2004) 1.17
Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR. J Hypertens (2004) 1.17
Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J (2003) 1.09
Identification and functional analysis of novel THAP1 mutations. Eur J Hum Genet (2011) 1.08
Sleep-stage-specific regulation of plasma catecholamine concentration. Psychoneuroendocrinology (2007) 1.05
Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation. Am J Physiol Regul Integr Comp Physiol (2009) 1.04
Angiotensin II induces catecholamine release by direct ganglionic excitation. Hypertension (2002) 1.03
Bradykinin, angiotensin-(1-7), and ACE inhibitors: how do they interact? Int J Biochem Cell Biol (2003) 1.01
Sympathetic function in human carriers of melanocortin-4 receptor gene mutations. J Clin Endocrinol Metab (2010) 1.00
Triggering receptor expressed on myeloid cells-1 (Trem-1) on blood neutrophils is associated with cytokine inducibility in human E. coli sepsis. Diagn Pathol (2013) 1.00
Remote vs. ischaemic preconditioning: the differential role of mitogen-activated protein kinase pathways. Cardiovasc Res (2007) 0.98
Cardiovascular and renal function of angiotensin II type-2 receptors. Cardiovasc Res (2004) 0.97
Restraint stress modulates brain, pituitary and adrenal expression of angiotensin II AT(1A), AT(1B) and AT(2) receptors. Neuroendocrinology (2002) 0.97
Biochemical characterization of kappaM-RIIIJ, a Kv1.2 channel blocker: evaluation of cardioprotective effects of kappaM-conotoxins. J Biol Chem (2010) 0.96
Endotoxemia causes central downregulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol (2008) 0.96
Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes. Diagn Pathol (2009) 0.95
Light and darkness fail to regulate melatonin release in critically ill humans. Intensive Care Med (2007) 0.94
Non-hypoxic induction of HIF-3alpha by 2-deoxy-D-glucose and insulin. Biochem Biophys Res Commun (2006) 0.94
Cold-induced alteration of adipokine profile in humans. Metabolism (2010) 0.93
Elevated resting and exercise-induced cortisol levels after mineralocorticoid receptor blockade with canrenoate in healthy humans. J Clin Endocrinol Metab (2004) 0.93
Orexin-stimulated MAP kinase cascades are activated through multiple G-protein signalling pathways in human H295R adrenocortical cells: diverse roles for orexins A and B. J Endocrinol (2009) 0.93
Nocturnal melatonin concentration is correlated with illness severity in patients with septic disease. Intensive Care Med (2006) 0.92
Bradykinin potentiation by ACE inhibitors: a matter of metabolism. Br J Pharmacol (2002) 0.91
Calcitonin gene related peptide mediates cardioprotection by remote preconditioning. Regul Pept (2005) 0.90
Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides (2002) 0.90
Effect of facial cooling and cold air inhalation on sympathetic nerve activity in men. Respir Physiol Neurobiol (2004) 0.90
Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic Biol Med (2005) 0.90
Intranasal leptin reduces appetite and induces weight loss in rats with diet-induced obesity (DIO). Endocrinology (2011) 0.89
Endothelial cell-derived nitric oxide enhances aerobic glycolysis in astrocytes via HIF-1α-mediated target gene activation. J Neurosci (2012) 0.89
Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein-1 gene. FASEB J (2004) 0.88
Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism (2005) 0.88
Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. J Clin Invest (2014) 0.87
Role of neuronal KATP channels and extraneuronal monoamine transporter on norepinephrine overflow in a model of myocardial low flow ischemia. J Pharmacol Exp Ther (2004) 0.87
Hyperglycemia in emergency patients--prevalence and consequences: results of the GLUCEMERGE analysis. Eur J Emerg Med (2015) 0.87
Ghrelin modulates baroreflex-regulation of sympathetic vasomotor tone in healthy humans. Am J Physiol Regul Integr Comp Physiol (2012) 0.86
Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? J Hypertens (2002) 0.86
Double blockade of angiotensin II (AT(1) )-receptors and ACE does not improve weight gain and glucose homeostasis better than single-drug treatments in obese rats. Br J Pharmacol (2012) 0.85
Organ-specific extravasation of albumin-bound Evans blue during nonresuscitated hemorrhagic shock in rats. Shock (2003) 0.85
Overfeeding-induced obesity in spontaneously hypertensive rats: an animal model of the human metabolic syndrome. Ann Nutr Metab (2010) 0.85
Angiotensin II stimulates the reactivity of the pituitary-adrenal axis in leptin-resistant Zucker rats, thereby influencing the glucose utilization. Am J Physiol Endocrinol Metab (2007) 0.85
Improved insulin sensitivity after long-term treatment with AT1 blockers is not associated with PPARγ target gene regulation. Endocrinology (2012) 0.85
Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism. J Pharmacol Exp Ther (2002) 0.84
Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling. J Cell Sci (2012) 0.84
Truncating mutations in THAP1 define the nuclear localization signal. Mov Disord (2011) 0.84
Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats. Brain Res (2007) 0.84
Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction. Eur J Pharmacol (2006) 0.84
Arterial elastance and its impact on intrinsic right ventricular function in palliated hypoplastic left heart syndrome. Int J Cardiol (2013) 0.84
Comparison of right ventricular deformation and dyssynchrony in patients with different subtypes of hypoplastic left heart syndrome after Fontan surgery using two-dimensional speckle tracking. Cardiol Young (2011) 0.83
Suppression of cardiac phosphatidate phosphohydrolase 1 activity and lipin mRNA expression in Zucker diabetic fatty rats and humans with type 2 diabetes mellitus. Biochem Biophys Res Commun (2009) 0.83
Neutral endopeptidase is activated in cardiomyocytes in human aortic valve stenosis and heart failure. Circulation (2002) 0.83
Influence of captopril on symptomatic and hormonal responses to hypoglycaemia in humans. Br J Clin Pharmacol (2003) 0.83
Agmatine, an endogenous ligand at imidazoline binding sites, does not antagonize the clonidine-mediated blood pressure reaction. Br J Pharmacol (2002) 0.83
Acute influences of estrogen and testosterone on divergent and convergent thinking in postmenopausal women. Neuropsychopharmacology (2003) 0.83
Cardiac kinin level in experimental diabetes mellitus: role of kininases. Am J Physiol Heart Circ Physiol (2003) 0.82
Blood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism. Br J Pharmacol (2012) 0.82
Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J Mol Neurosci (2011) 0.82
Heart rate variability and metabolic rate in healthy young adults with low birth weight. Am J Cardiovasc Dis (2013) 0.82
Radioprotective effect of lidocaine on function and ultrastructure of salivary glands receiving fractionated radiation. Int J Radiat Oncol Biol Phys (2012) 0.81
Nesfatin-1 increases energy expenditure and reduces food intake in rats. Obesity (Silver Spring) (2014) 0.81
Long-term results of autologous submandibular gland transfer for the surgical treatment of severe keratoconjunctivitis sicca. J Craniomaxillofac Surg (2008) 0.81
Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors. Endocrinology (2003) 0.81
QRFP induces aldosterone production via PKC and T-type calcium channel-mediated pathways in human adrenocortical cells: evidence for a novel role of GPR103. Am J Physiol Endocrinol Metab (2013) 0.80
Reduction of vascular noradrenaline sensitivity by AT1 antagonists depends on functional sympathetic innervation. Hypertension (2004) 0.80
Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure. Naunyn Schmiedebergs Arch Pharmacol (2011) 0.80